Certara, Inc.

Certara, Inc. is a provider of biosimulation software and technology-enabled services for the biopharmaceutical industry. Headquartered in Radnor, Pennsylvania, the company helps drug developers and regulatory agencies simulate drug behavior, optimize clinical trials, and streamline regulatory submissions. Its solutions are designed to accelerate the drug discovery and development process while reducing the need for human and animal testing.

Financials

Earnings Transcripts

Leadership & board

Acquisitions

No single customer accounted for more than 10% of revenues in 2025. Certara's ten largest customers represented approximately 24% of revenues for the year ended December 31, 2025 (down from 27% in 2024). Certara serves biopharma/life-sciences customers plus adjacent markets including animal health, crop science, bioscience, medical devices and the public sector; the 10-K flags reliance on a key group of customers as a risk factor.

You're subscribed.

Thanks for signing up.